Medium Biosciences
AI-designed Protein Therapeutics
San Francisco, United States · Founded 2021
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2021
- Website
- medium.bio
- Last Round
- SeedMar 2021
- Rounds
- 1
About
We develop AI models & new assays to create functional, therapeutic proteins.
Summary
Medium Biosciences is an Artificial Intelligence company based in San Francisco, United States, founded in 2021. Its most recent funding was a Seed round in Mar 2021. Investors include E14 Fund, AIX Ventures and Village Global.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2021
Investors
Similar Companies
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Global contract research organization providing comprehensive drug development and laboratory ser...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company